HDL METABOLISM IN ABETALIPOPROTEINEMIA - ACCELERATED CATABOLISM OF HDL CONTAINING APOA-I AND APOE

被引：0
|
作者：
IKEWAKI, K [1 ]
RADER, DJ [1 ]
ZECH, LA [1 ]
BREWER, HB [1 ]
机构：
[1] NHLBI,MDB,BETHESDA,MD 20892
来源：
CIRCULATION | 1993年 / 88卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [21] HDL, ApoA-I and ApoE-Mimetic Peptides: Potential Broad Spectrum Agent for Clinical Use?
    Sunil A. Nankar
    Priyanka S. Kawathe
    Abhay H. Pande
    International Journal of Peptide Research and Therapeutics, 2022, 28
  • [22] DISTRIBUTION OF SUBCLASSES OF HDL CONTAINING APOA-I WITHOUT APOA-II (LPA-I) IN NORMOLIPIDEMIC MEN AND WOMEN
    DUVERGER, N
    RADER, D
    BREWER, HB
    ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (10): : 1594 - 1599
  • [23] Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients
    S. S. Soedamah-Muthu
    H. M. Colhoun
    M.-R. Taskinen
    B. Idzior-Walus
    J. H. Fuller
    Diabetologia, 2000, 43 : 1353 - 1359
  • [24] Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome
    Rached, Fabiana
    Santos, Raul D.
    Camont, Laurent
    Miname, Marcio H.
    Lhomme, Marie
    Dauteuille, Carolane
    Lecocq, Sora
    Serrano, Carlos V., Jr.
    Chapman, M. John
    Kontush, Anatol
    JOURNAL OF LIPID RESEARCH, 2014, 55 (12) : 2509 - 2520
  • [25] CHANGES IN HDL, CRP, APOE, APOB AND APOA-I APOPROTEIN LEVELS INDUCED BY ACUTE INFLAMMATORY CONDITIONS IN CHILDREN
    Tziouvas, K.
    Triantafyllidis, G.
    Anthopoulou, A.
    Damianaki, D.
    ACTA PAEDIATRICA, 2009, 98 : 251 - 251
  • [26] Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
    Thorngate, FE
    Yancey, PG
    Kellner-Weibel, G
    Rudel, LL
    Rothblat, GH
    Williams, DL
    JOURNAL OF LIPID RESEARCH, 2003, 44 (12) : 2331 - 2338
  • [27] A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE-/-mice
    Gou, Sanhu
    Wang, Li
    Zhong, Chao
    Chen, Xinyue
    Ouyang, Xu
    Li, Beibei
    Bao, Guangjun
    Liu, Hui
    Zhang, Yun
    Ni, Jingman
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (20) : 4627 - 4644
  • [28] PRODUCTION OF APOA-I IN HDL FOLLOWING TRANSFECTION OF THE HUMAN APOA-I GENE INTO 3T3 CELLS
    ORDOVAS, JM
    MANDEL, G
    GOODMAN, RH
    SCHAEFER, EJ
    CIRCULATION, 1986, 74 (04) : 285 - 285
  • [29] ApoA-I knockout mice: Characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes
    Plump, AS
    Azrolan, N
    Odaka, H
    Wu, L
    Jiang, X
    Tall, A
    Eisenberg, S
    Breslow, JL
    JOURNAL OF LIPID RESEARCH, 1997, 38 (05) : 1033 - 1047
  • [30] COMPARISON OF THEORETICAL AND EXPERIMENTAL RELATIONSHIPS BETWEEN HDL SIZE AND THE RATIO OF HDL CHOLESTEROL (HDL-C) TO APOLIPOPROTEIN A-I (APOA-I)
    Mazer, N. A.
    Mora, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 43 - 43
12345